GL1X · GenesisL1 explorer

MolNFT v1 · #143531 · protein

Structure of full length human ampk (A2B2G1) in complex with a small molecule activator SC4.

6B2E: “Structure of full length human ampk (A2B2G1) in complex with a small molecule activator SC4.”. X-ray diffraction, 4 ligands (AMP, STU, CG7). MolNFT v1 #143531 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6B2E
Type
protein
Length
931 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P54646, O43741, P54619
Ligands
AMP, STU, CG7, GLC

Structure

x-ray diffraction · 3 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein443—P54646
B—protein193—O43741
C—protein295—P54619

Ligands and binding sites

  • AMP · Adenosine monophosphate · ligand · 2 copies · chains A, C
  • STU · Staurosporine · ligand · chains A
  • CG7 · 5-{[6-chloro-5-(2'-hydroxy[1,1'-biphenyl]-4-yl)-1H-imidazo[4,5-b]pyridin-2-yl]oxy}-2-methylbenzoic acid · ligand · chains A, B
  • GLC · alpha-D-glucopyranose · sugar · 7 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6B2E · Structure of full length human AMPK (a2b2g1) in complex with a small molecule activator… · the same entry in another collection · chain A against A, TM-score 1.00
  • P54619 · AlphaFold monomer V2.0 prediction for 5'-AMP-activated protein kinase subunit gamma-1… · a predicted model of the same protein · chain C against A, TM-score 0.96
  • P54646 · AlphaFold monomer V2.0 prediction for 5'-AMP-activated protein kinase catalytic subunit… · a predicted model of the same protein · chain A against A, TM-score 0.95
  • O43741 · AlphaFold monomer V2.0 prediction for 5'-AMP-activated protein kinase subunit beta-2… · a predicted model of the same protein · chain B against A, TM-score 0.86

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.